Soluble IL-18 receptor complex: a new star in the firmament of rheumatoid arthritis diagnosis?

Soluble interleukin-18 receptor complex is a novel biomarker in rheumatoid arthritis

(2011) Satoko Takei et al.   ARTHRITIS RESEARCH & THERAPY

Anti-CCP Antibody, a Marker for the Early Detection of Rheumatoid Arthritis

(2009) Walther J. van Venrooij et al.   Annals of the New York Academy of Sciences

The natural soluble form of IL-18 receptor   exacerbates collagen-induced arthritis via modulation of T-cell immune responses

(2009) S Veenbergen et al.   ANNALS OF THE RHEUMATIC DISEASES

Synovial tissue and serum biomarkers of disease activity, therapeutic response and radiographic progression: analysis of a proof-of-concept randomised clinical trial of cytokine blockade

(2009) T. Rooney et al.   ANNALS OF THE RHEUMATIC DISEASES

CD11c as a Transcriptional Biomarker to Predict Response to Anti-TNF Monotherapy With Adalimumab in Patients With Rheumatoid Arthritis

(2009) B Stuhlmüller et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

An Eight-Gene Blood Expression Profile Predicts the Response to Infliximab in Rheumatoid Arthritis

(2009) Antonio Julià et al.   PLoS One